A new case report published in Clinical Neurophysiology describes the first known administration of psilocybin—a psychedelic ...

A small pilot study has found that psilocybin, the active compound in psychedelic mushrooms, may improve not only mood but ...

Harm caused by repeated concussions, especially in the context of sports, has gained attention in both research and the media ...

In this episode of the Love Letters podcast, a couple explains how traveling to Oregon for psilocybin treatment changed their ...

Discover how psilocybin therapy could transform Parkinson’s care - read more about this promising pilot trial and future ...

The prevalence of lifetime and past-year use of psilocybin increased from 2019 to 2023 among all age groups in the United States.

In the midst of a statewide and national debate about the clinical use of psilocybin, Sean Schriver thinks of two people in ...

Use of psilocybin has increased among all age groups since some states decriminalized the hallucinogen in 2019.

Increase seen in lifetime use among adults and adolescents; past-year use higher among young adults, older adults.

Researchers at Mass General Brigham discovered that interactions between immune cells and brain cells play a key role in ...

Colorado lawmakers are considering legislation that would charge the state health agency to collect data and information on ...

A new pilot study reveals that psilocybin—the compound found in psychedelic mushrooms—may significantly improve mood, ...